23 February 2024 (Friday) - Oncology Central Update

The nice people at Oncology Central sent their update today. All a bit over my head, but stuff I need to be aware of…

Uncovering the link between cancer disparities and climate change

 

What disparities exist in cancer screening and how does this impact patient outcomes? Listen to our latest podcast episode with Dr Kilan Ashad-Bishop from the American Cancer Society to find out.

JOURNAL ARTICLES

Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union

Trastuzumab-anns is a biosimilar to trastuzumab, which is approved by the EMA and US FDA for treatment of HER2+ early and metastatic breast cancer. Read about its use in seven clinical oncology practices in the EU.

MORE >>>

BIPOC involvement in oncological research: insights from Future Oncology

In this special edition of editor’s highlights, Michael Bell Managing Editor, looks at three articles published over the last 12 months in Future Oncology, concerning greater engagement and representation for Black, Indigenous and People of Colour (BIPOC) people in oncological research.

MORE >>>

P-REALITY X: prolonging metastatic breast cancer survival by adding palbociclib to an aromatase inhibitor

Find out details of a real-world database analysis exploring how adding palbociclib to an aromatase inhibitor could prolong the life of people with metastatic HR+/HER2– breast cancer in routine clinical practice. 

MORE >>>

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)